Ignite Creation Date:
2025-12-24 @ 2:52 PM
Ignite Modification Date:
2025-12-26 @ 7:54 AM
Study NCT ID:
NCT01728259
Status:
TERMINATED
Last Update Posted:
2023-05-09
First Post:
2012-11-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
First-line Pomalidomide, Bortezomib, and Dexamethasone For AL Amyloidosis or LCDD
Sponsor:
Barbara Ann Karmanos Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-03
Start Date Type:
ACTUAL
Primary Completion Date:
2018-10-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-10-31
Completion Date Type:
ACTUAL
First Submit Date:
2012-11-13
First Submit QC Date:
None
Study First Post Date:
2012-11-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-05-05
Last Update Post Date:
2023-05-09
Last Update Post Date Type:
ACTUAL